Literature DB >> 19601790

2-Arylbenzothiazole as a privileged scaffold in drug discovery.

A A Weekes1, A D Westwell.   

Abstract

Substituted 2-arylbenzothiazoles have emerged in recent years as an important pharmacophore in a number of diagnostic and therapeutic settings. Attractive features of drug candidates based on this benzothiazole scaffold include their synthetic accessibility, and synthetic approaches to 2-arylbenzothiazole-based compounds will be reviewed here. Examples of 2-arylbenzothiazoles endowed with diagnostic/therapeutic activity include the 2-(4-aminophenyl)benzothiazole series, which has a remarkable activity profile in both the potential non-invasive diagnosis of Alzheimer's disease and as antitumour agents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19601790     DOI: 10.2174/092986709788682137

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  12 in total

1.  Characterization of the 4-(benzothiazol-2-yl)phenylnitrenium ion from a putative metabolite of a model antitumor drug.

Authors:  Mrinal Chakraborty; Kyoung Joo Jin; Stephen A Glover; Michael Novak
Journal:  J Org Chem       Date:  2010-08-06       Impact factor: 4.354

2.  Highly efficient water-mediated approach to access benzazoles: metal catalyst and base-free synthesis of 2-substituted benzimidazoles, benzoxazoles, and benzothiazoles.

Authors:  Manju Bala; Praveen Kumar Verma; Deepika Sharma; Neeraj Kumar; Bikram Singh
Journal:  Mol Divers       Date:  2015-03-11       Impact factor: 2.943

3.  Eco-friendly synthesis, in vitro anti-proliferative evaluation, and 3D-QSAR analysis of a novel series of monocationic 2-aryl/heteroaryl-substituted 6-(2-imidazolinyl)benzothiazole mesylates.

Authors:  Livio Racané; Lucija Ptiček; Mirela Sedić; Petra Grbčić; Sandra Kraljević Pavelić; Branimir Bertoša; Irena Sović; Grace Karminski-Zamola
Journal:  Mol Divers       Date:  2018-04-17       Impact factor: 2.943

Review 4.  Privileged scaffolds for library design and drug discovery.

Authors:  Matthew E Welsch; Scott A Snyder; Brent R Stockwell
Journal:  Curr Opin Chem Biol       Date:  2010-03-18       Impact factor: 8.822

5.  Liposomal Formulations of a New Zinc(II) Complex Exhibiting High Therapeutic Potential in a Murine Colon Cancer Model.

Authors:  Nádia Ribeiro; Melissa Albino; Andreia Ferreira; Cristina Escrevente; Duarte C Barral; João Costa Pessoa; Catarina Pinto Reis; Maria Manuela Gaspar; Isabel Correia
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

6.  Investigation on Optical and Biological Properties of 2-(4-Dimethylaminophenyl)benzothiazole Based Cycloplatinated Complexes.

Authors:  Rebeca Lara; Gonzalo Millán; M Teresa Moreno; Elena Lalinde; Elvira Alfaro-Arnedo; Icíar P López; Ignacio M Larráyoz; José G Pichel
Journal:  Chemistry       Date:  2021-10-07       Impact factor: 5.020

7.  Chemistry of ring-substituted 4-(benzothiazol-2-yl)phenylnitrenium ions from antitumor 2-(4-aminophenyl)benzothiazoles.

Authors:  Yang Zhang; Mrinal Chakraborty; Christian G Cerda-Smith; Ryan N Bratton; Natalie E Maurer; Ethan M Senser; Michael Novak
Journal:  J Org Chem       Date:  2013-07-01       Impact factor: 4.354

Review 8.  Current advances in the synthetic strategies of 2-arylbenzothiazole.

Authors:  Ayushi Sethiya; Nusrat Sahiba; Pankaj Teli; Jay Soni; Shikha Agarwal
Journal:  Mol Divers       Date:  2020-11-12       Impact factor: 2.943

9.  Direct catalytic arylation of heteroarenes with meso-bromophenyl-substituted porphyrins.

Authors:  Alexei Nikolaevich Kiselev; Olga Konstantinovna Grigorova; Alexei Dmitrievich Averin; Sergei Aleksandrovich Syrbu; Oskar Iosifovich Koifman; Irina Petrovna Beletskaya
Journal:  Beilstein J Org Chem       Date:  2017-08-03       Impact factor: 2.883

10.  Novel Thiazolo[5,4-b]phenothiazine Derivatives: Synthesis, Structural Characterization, and In Vitro Evaluation of Antiproliferative Activity against Human Leukaemia.

Authors:  Balazs Brem; Emese Gal; Luiza Găină; Luminiţa Silaghi-Dumitrescu; Eva Fischer-Fodor; Ciprian Ionuţ Tomuleasa; Adriana Grozav; Valentin Zaharia; Lorena Filip; Castelia Cristea
Journal:  Int J Mol Sci       Date:  2017-06-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.